Nebulized hypertonic saline solution for acute bronchiolitis in infants

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Zhang, Linjie ^a   Mendoza Sassi, Raúl A ^a   Wainwright, Claire ^b   Klassen, Terry P ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acute disease; Bronchiolitis, viral *therapy ; Bronchodilator agents administration dosage ; Humans; Infant; Nebulizers and vaporizers; Randomized controlled trials as topic; Saline solution, hypertonic *administration dosage

Indexed keywords

BRONCHODILATING AGENT; SODIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; ACUTE DISEASE; BRONCHIOLITIS; CHILD HOSPITALIZATION; CLINICAL TRIAL; HOSPITAL PATIENT; HUMAN; INFANT DISEASE; LENGTH OF STAY; NEBULIZATION; OUTPATIENT; REVIEW; SCORING SYSTEM; VIRAL BRONCHIOLITIS;

EID: 77950233280     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Kuzik 2007 {published data only} Kuzik BA, Al Qaghi SA, Kent S, Flavin MP, Hopman W, Hotte S, et al.Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. Journal of Pediatrics 2007;151:266-70.
2. Mandelberg 2003 {published data only} Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, et al.Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003;123:481-7.
3. Sarrell 2002 {published data only} Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA, et al.Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest 2002;122:2015-20.
4. Tal 2006 {published data only} Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. The Israel Medical Association Journal 2006;8:169-73.
5. Amirav 2005 {published data only} Amirav I, Oron A, Tal G, Cesar K, Ballin A, Houri S, et al.Aerosol delivery in RSV bronchiolitis: hood or face-mask?. Journal of Pediatrics 2005;147(5):627-31.
6. Guomo 2007 {published data only} Guomo R, Cossettini M, Saretta F, Fasoli L, Guerrera T, Canciani M. Efficacy of hypertonic saline solution in infants with acute bronchiolitis. European Respiratory Journal 2007; Vol. 30, issue Suppl:51, E3016.
7. Tribastone 2003 {published data only} Tribastone AD. Nebulized 3% saline effective for viral bronchiolitis. The Journal of Family Practice 2003;52(5):359-60.
8. Assouline 1977 Assouline G, Leibson V, Danon A. Stimulation of prostaglandin output from rat stomach by hypertonic solution. European Journal of Pharmacology 1977;44:271-3.
9. Bertrand 2001 Bertrand P, Aranibar H, Castro E, Sanchez I. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatric Pulmonology 2001;31(4):284-8.
10. Daviskas 1996 Daviskas E, Anderson SD, Gonda I, Eberl S, Meikle S, Seale JP, et al.Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. European Respiratory Journal 1996;9(4):725-32.
11. Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
12. Garcia-Garcia 2006 Garcia-Garcia ML, Calvo C, Perez-Brena P, De Cea JM, Acosta B, Casas I. Prevalence and clinical characteristics of human metapneumovirus infections in hospitalized infants in Spain. Pediatric Pulmonology 2006;41(9):863-71.
13. Hartling 2006 Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD003123.pub2]
14. Henderson 1979 Henderson FW, Clyde WA Jr, Collier AM, Denny FW, Senior RJ, Sheaffer CI, et al.The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. Journal of Pediatrics 1979;95: 183-90.
15. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60.
16. Jacques 2006 Jacques J, Bouscambert-Duchamp M, Moret H, Carquin J, Brodard V, Lina B, et al.Association of respiratory picornaviruses with acute bronchiolitis in French infants. Journal of Clinical Virology 2006;25(4):463-6.
17. Jadad 1996 Jadad A, Moore AR, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
18. Kellett 2005 Kellett F, Redfern J, Niven RM. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respiratory Medicine 2005;99(1):27-31.
19. Klassen 1997a Klassen TP. Recent advances in the treatment of bronchiolitis and laryngitis. Pediatric Clinics of North America 1997;44(1):249-61.
20. Klassen 1997b Klassen TP, Sutcliffe T, Watters LK, Wells GA, Allen UD, Li MM. Dexamethasone in salbutamol-treated in patients with acute bronchiolitis: a randomized, controlled trial. Journal of Pediatrics 1997;130:191-6.
21. Lowell 1987 Lowell DI, Lister G, Von Kloss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics 1987;87:939- 45.
22. Meissner 2003 Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection.. Pediatric Infectious Disease Journal 2003;22(2 Suppl):S40-4.
23. Nasr 2001 Nasr SZ, Strouse PJ, Soskoline E, Maxvold NJ, Garver KA, Rubin BK, et al.Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest 2001;120(1):203-8.
24. Njoo 2001 Njoo H, Pelletier L, Spika L. Respiratory disease in Canada. Ottawa: Canadian Institute for Health Information, Health Canada and Statistics Canada 2001:65-87.
25. Panitch 1993 Panitch HB, Callahan CW, Schidlow DV. Bronchiolitis in children. Clinics in Chest Medicine 1993;14(4):715-31.
26. Panitch 2003 Panitch HB. Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction. Pediatric Infectious Disease Journal 2003;22(Suppl): 83-8.
27. Perrotta 2006 Perrotta C, Ortiz Z, Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD004873.pub3]
28. Rakshi 1994 Rakshi K, Couriel JM. Management of acute bronchiolitis. Archives of Disease in Childhood 1994;71(5):463-9.
29. RevMan 2008 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagan: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
30. Robinson 1997 Robinson M, Hemming A, Regnis J,Wong A, Bailey D, Bautotvich GJ, et al.Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997; 52(10):900-3.
31. Rose 1987 Rose RM, Pinkston P, O'Donnell C, Jensen WA. Viral infection of the lower respiratory tract. Clinical Chest Medicine 1987;8:405-18.
32. Schuh 1992 Schuh S, Johnson D, Canny G, Reisman J, Shields M, Kovesi T, et al.Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Pediatrics 1992;90:920- 3.
33. Shay 1999 Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis hospitalizations. JAMA 1999;282(15): 1440-6.
34. Shay 2001 Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncitial virus-associated deaths among US children 1979-1997. Journal of Infectious Diseases 2001;183:16-22.
35. Shoseyov 1998 Shoseyov D, Bibi H, Shai P, Ahoseyov N, Shazberg G, Hurvitz H. Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. Journal of Allergy and Clinical Immunology 1998;101(5):602-5.
36. Wainwright 2003 Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D, et al.A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. New England Journal of Medicine 2003;349:27-35.
37. Wang 1992 Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. American Review of Respiratory Diseases 1992; 145(1):106-9.
38. Wark 2007 Wark PAB, McDonald V, Jones AP. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD001506.pub2]
39. Wohl 1978 Wohl MEB, Chernick V. State of the art: bronchiolitis. American Review of Respiratory Diseases 1978;118:759-81.
40. Wohl 2003 Wohl ME, Chernick VC. Treatment of acute bronchiolitis. New England Journal of Medicine 2003;349:82-3.
41. Zhang 2003 Zhang L, Ferruzzi E, Bonfanti T, Auler MI, Davila NE, Faria CS, et al.Long and short-term effect of prednisolone in hospitalized infants with acute bronchiolitis. Journal of Paediatrics and Child Health 2003;39:548-51.
42. Ziment 1978 Ziment I. Respiratory pharmacology and therapeutics. Philadelphia: WB Saunders, 1978.